Global CBD Study Calls For Tighter Regulation And Clinical Trials

A wide-ranging study of low-dose cannabidiol supplementation, its regulation, efficacy and safety calls for improved legislation, guidelines and quality control together with clinical trials exploring the increasingly popular ingredient's therapeutic benefits.

CBD_THCstudy_1470434714_1200.jpg
• Source: Shutterstock

A study comparing cannabidiol availability across in nine countries – Australia, Canada, Germany, Ireland, Japan, New Zealand, Switzerland, UK and US – shows a wide variety of approaches in how access to CBD products is regulated.

A range of CBD products, including oils, gel capsules, purified crystal and topical products, were accessible without prescription in seven...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Cannabis/CBD

More from Ingredients & Safety